Basics FibroGen, Inc FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. IPO Date: November 14, 2014 Sector: Healthcare Industry: Biotech Market Cap: $32.49M Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 3.02% Avg Daily Range (30 D): $0.01 | 4.11% Avg Daily Range (90 D): $0.02 | 4.82% Institutional Daily Volume Avg Daily Volume: .9M Avg Daily Volume (30 D): .55M Avg Daily Volume (90 D): 1.91M Trade Size Avg Trade Size (Sh.): 139 Avg Trade Size (Sh.) (30 D): 653 Avg Trade Size (Sh.) (90 D): 554 Institutional Trades Total Inst.Trades: 4,014 Avg Inst. Trade: $2.18M Avg Inst. Trade (30 D): $.84M Avg Inst. Trade (90 D): $.84M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.89M Avg Closing Trade (30 D): $9.03M Avg Closing Trade (90 D): $9.03M Avg Closing Volume: 123.42K         News Feb 20, 2025 @ 6:08 PM Amid Mounting Pressure In China, AstraZeneca Buys ... Source: Vandana Singh Sep 2, 2024 @ 8:15 PM Liver Fibrosis Market Is Expected to Reach USD 43.... Source: The Brainy Insights Aug 23, 2024 @ 10:04 PM Catalyst Accelerator Ogden Selects 11 Companies fo... Source: Catalyst Accelerator Ogden Jun 3, 2024 @ 8:48 PM FibroGen Stock Is Surging After The Bell: What's G... Source: Adam Eckert Jun 3, 2024 @ 8:05 PM FibroGen Announces Clinical Trial Supply Agreement... Source: FibroGen, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.1 $.05 $.18 Diluted EPS $-.1 $.05 $.18 Revenue $ -23.54M $ 2.74M $ -123.26M Gross Profit $ -13.6M $ 2.49M $ -102.59M Net Income / Loss $ -10.01M $ 4.64M $ 17.98M Operating Income / Loss $ -134.27M $ -14.92M $ -91.66M Cost of Revenue $ -9.94M $ .25M $ -20.67M Net Cash Flow $ 61.27M $ 2.62M $ 34.01M PE Ratio